RAPID, AFFORDABLE
COVID-19 DETECTION and variant identification.
COVID-19 DETECTION and variant identification.
DETECTION MADE ACCESSIBLE.
Rapid, affordable Variant Detection for SARS-CoV-2 is now available thanks to the PathogenDx Microarray. Our NIH-supported technology provides invaluable insight to guide scientific discovery and public health decision- making—today not someday. And without the time and expense of sequencing.
US: For Research Use Only
- Variant results in 4 hours after positive sample from a Q-PCR test
- Run up to 576 samples in a single shift
- A fraction of the cost of NGS
- Uses standard lab equipment
- No High-end bioinformatics required
- High-throughput COVID-19 detection and variant identification in a single test
- Limit of detection of 1,000 copies-mL
- A fraction of the time and cost of NGS
- Uses standard lab equipment
- No high-end bioinformatics required
The Technology at a glance: DetectX-Cv is a Multiplexed MicroArray technology that identifies SARS-CoV-2 variants in RNA isolated from samples utilizing our patented Asymmetric One-Step RT-PCR coupled with a DNA MicroArray Hybridization. The SARS-CoV-2 viral mutation targets are simultaneously identified and include: COVID-19 (Wuhan N1, N2) and Clades (EU, UK, Brazil, Japan, India, US).
COMPARING COVID-19 VARIANT
DETECTION TECHNOLOGIES.
DETECTION TECHNOLOGIES.
Technology
Mass Array Panel
NGS Sequencing
Time To Results
4 hr
8 hr
96 hr
Test Cost
$25
$25
$150-$400
Equipment Cost
<$60K
$250K+
$850K-$1M
WORKFLOW: SARS-CoV-2+VARIANT DETECTION IN 6.5 HOURS
PathogenDx testing is supported by The National Institutes of Health (NIH) as part of the Rapid Acceleration of Diagnostics (RADx) program. DetectX-Cv joins DetectX-Rv as part of our rapid response in innovation to address COVID-19.
INQUIRE ABOUT PATHOGENDx
CLADE VARIANT DETECTION
Read our Variant Detection
Press Release.
Press Release.
Discover more about
PathogenDx and its solutions.
PathogenDx and its solutions.
Variant/Mutation Identification is designed for Research Use Only (RUO)
